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Abstract
Aims: ApoB-100 is the major protein component of cholesterol- and triglyceride-rich LDL and VLDL lipoproteins in the
serum. Previously, we generated and partially described transgenic mice overexpressing the human ApoB-100 protein. Here,
we further characterize this transgenic strain in order to reveal a possible link between hypeprlipidemia and
neurodegeneration.
Methods and Results: We analyzed the serum and cerebral lipid profiles, tau phosphorylation patterns, amyloid plaque-
formation, neuronal apoptosis and synaptic plasticity of young (3 month old), adult (6 month old) and aging (10–11 month
old) transgenic mice. We show that ApoB-100 transgenic animals present i) elevated serum and cerebral levels of
triglycerides and ApoB-100, ii) increased cerebral tau phosphorylation at phosphosites Ser199, Ser199/202, Ser396 and Ser404.
Furthermore, we demonstrate, that tau hyperphosphorylation is accompanied by impaired presynaptic function, long-term
potentiation and widespread hippocampal neuronal apoptosis.
Conclusions: The results presented here indicate that elevated ApoB-100 level and the consequent chronic
hypertriglyceridemia may lead to impaired neuronal function and neurodegeneration, possibly via hyperphosphorylation
of tau protein. On account of their specific phenotype, ApoB-100 transgenic mice may be considered a versatile model of
hyperlipidemia-induced age-related neurodegeneration.
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Introduction
Over the last few years, increasing number of evidence has
highlighted the relationship between hyperlipidemia-induced
cerebrovascular disorders and age-related cognitive decline [1].
Vascular dementia is a common cause of cognitive decline in the
elderly and is associated with atherogenic dyslipidemia being
specifically related to low density lipoprotein (LDL) and carotid
atherosclerosis [2]. Elevated level of LDL leads to the development
of atherogenesis and cardiovascular failure [3]. The major protein
component of cholesterol- and triglyceride-rich LDL and VLDL
lipoproteins is the apolipoprotein B-100 (ApoB-100), a 512 kDa
lipoprotein. Recent studies indicate that ApoB-100-induced
hyperlipidemia and atherosclerosis are not only implicated in the
pathogenesis of cardiovascular disease but may also affect the
cerebrovascular system [4] thus contribute to the development of
neurodegenerative disorders [5]. Other studies have shown that
Alzheimer’s disease (AD) is accompanied by an elevation in
apolipoprotein B concentration in the serum [6,7]. AD represents
the vast majority of all dementia cases. Most of AD cases are
sporadic, less than 5% of cases of Alzheimer’s disease (AD) can be
traced to genetic causes, thus strengthening the hypothesis that
lifestyle and nutrition-related factors may contribute to the
development of metabolic syndrome and vascular lesions that
eventually lead to neurodegenerative disorders [8].
The three major pathological hallmarks of AD are the
extracellular deposition of amyloid beta, the formation of
neurofibrillary tangles (NFT) and neuronal cell loss [9,10,11,12].
Accumulation and plaque formation of Abeta peptide is the result
of abnormal cleavage of amyloid precursor protein (APP) [10] and
failure of amyloid clearance by enzymatic degradation, phagocy-
tosis and cerebral perivascular transport [13,14,15]. Tau is a
microtubule-associated phosphoprotein involved in microtubule
assembly and stabilization. Hyperphosphorylation of tau leads to
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destabilization and disintegration of microtubular network and
formation of neurofibrillary tangles (NFT) [11].
Previously, we generated a transgenic mouse strain overex-
pressing the human ApoB-100 protein [16]. On a standard diet,
elevated serum triglyceride level, on cholesterol high diet an
increased serum total cholesterol level and coronary atherosclero-
sis were observed [17]. High serum lipid level (hypertriglyceride-
mia and/or hypercholesterolemia) seriously affects the condition of
cerebral arterial walls, gradually leading to a significant decrease in
cortical microvascular density in ApoB-100 transgenic mice [4].
Cerebral microvascular lesions may cause: a) cerebral ischemia/
hypoxia which in turn induces oxidative stress via the upregulation
of NOS proteins; b) glucose-deprivation in cortical neurons, which
may directly lead to apoptosis and neurodegeneration. It has also
been shown that starvation induces tau hyperphosphorylation in
the hippocampus and cortical tissues of mice [18].
The current work provides further insights into the interrela-
tionship between hypertriglyceridemia and neurodegeneration.
Using a previously generated transgenic mouse model we
demonstrate here, that overexpression of human ApoB-100 leads
to chronic hypertriglyceridemia, which in turn affects tau
phosphorylation - without substantial amyloid accumulation-,
eventually resulting in neurodegeneration and impaired long-term
potentiation.
Materials and Methods
Animals
The study conformed to EU Directive 2010/63/EU and was
approved by the regional Station for Animal Health and Food
Control (Csongrad-county, Hungary) under Project License XVI/
02752/2009. ApoB-100 transgenic mice were produced in our
laboratory as described previously [16]. Transgenic mice were
backcrossed with C57B/6 strain six times to achieve a homoge-
nous genetic background. Young (3 month old), adult (6 month
old) and aging (10–11 month old) mice were used in this study.
Animals were maintained on a regular rodent chow diet. Animal
surgeries were performed under sodium pentobarbital (Nembutal)
anesthesia and all efforts were made to minimize pain and
suffering.
Measurement of serum triglyceride levels
Blood was collected from the tail vein of young and aging mice.
Plasma total triglyceride levels were measured in triplicate
according to the manufacturer’s instructions using a commercially
available enzymatic colorimetric assay kit (Diagnosticum Ltd.,
Budapest, Hungary). Test accuracy was monitored using Standard
Lipid Controls (Diagnosticum Ltd., Budapest, Hungary), and
colorimetric reactions were measured at 546 nm. Values were
expressed in mmol/liter. Experimental groups (transgenic mice
and wild-type littermates) consisted of 6 animals each.
Lipid staining
The brains of adult and aging transgenic and wild-type mice
were removed after transcardiac perfusion with isotonic saline.
Tissues were postfixed with 4% formaldehyde-PBS solution for 1 h
prior to embedding. Nile Red (Fluka) stain [19] was dissolved in
acetone, and 10 mm acetone postfixed cryosections were stained at
room temperature for 1 h in the dark [20]. Nuclei were
counterstained using DAPI, and red and yellow-gold fluorescence
was detected using a Nikon fluorescent microscope equipped with
590 nm and 528 nm filters, respectively. Cholesterol was stained
with 0.05 mg/ml filipin-PBS solution at 37uC for 30 min in the
dark (Filipin Complex was purchased from Sigma). Nuclei were
counterstained with propidium iodide. Blue fluorescence was
detected using a Nikon fluorescent microscope equipped with a
340–380 nm filter.
Immunohistochemistry
Acetone-fixed brain cryosections (8–10 mm) from young and
adult transgenic and wild type mice were prepared and incubated
overnight with anti-ApoB-100 (Millipore, 1:500), ApoE (Santa
Cruz Biotech., 1:100), and anti-pTauSer404 phosphospecific
(Invitrogen, 1:200) polyclonal antibodies. Sections were pretreated
with 10 mg/ml collagenase type I (Sigma) for 10 min followed by
an 1 hr incubation in 5% rabbit serum in PBS. Next, HRP-
conjugated rabbit anti-goat or goat anti-rabbit secondary anti-
bodies (Jackson Immuno Research) were added to the sections for
45 min at 1:250 to 1:800 dilutions. Peroxidase was detected using
a reagent containing AEC (3-Amino-9-ethylcarbazole, Sigma).
Amyloid plaques were immunostained on brain sections of adult
and aging mice using anti- Ab [1–42] (Invitrogen, 1:200)
polyclonal antibody and Congo-Red (Sigma) staining.
Conventional western blotting
The lipoprotein content of cortical brain lysates from adult
transgenic and wild-type mice were evaluated using semi-
quantitative western blotting. Samples containing 50 mg of total
proteins were loaded onto a denaturing SDS-polyacrylamide gel,
blotted to PVDF membrane, blocked with 3% BSA-TPBS or 5%
non-fat milk-TPBS solution for 1 h and labeled with the
corresponding primary antibody, specifically, anti-Apolipoprotein
B-100 (Chemicon Int., 1:500), anti-Apolipoprotein A-I (Rockland,
1:500), anti-LDLr (Santa Cruz Biotech., 1:100), anti-Apolipopro-
tein E (Santa Cruz Biotech., 1:100), and anti b-actin (Sigma,
50 ng/ml) polyclonal antibodies, overnight at 4uC.To compare
tau phosphorylation intensities in transgenic vs. wild-type mice the
following site-specific primary antibodies were applied: anti-pTau
Ser199/202 (Invitrogen, 1:500), pTau Ser262 (Invitrogen, 1:100),
pTau Ser396 (Invitrogen, 1:1000), pTau Ser404 (Invitrogen,
1:3000). Total amount of tau protein was estimated using anti-
TauV-20 antibody (Santa Cruz Biotech, 1:100). APP content of
young and adult mouse brains was determined using anti-APP N-
terminal specific monoclonal antibody (Chemicon Int, 1:1000).
Then filters were washed and incubated with the corresponding
secondary antibody (Jackson ImmunoResearch, at 1:20,000–
40,000 dilutions) for 45 min at RT. The signal was enhanced
using Luminata Forte Western HRP Substrate (Millipore) and
detected on Kodak X-ray film.
Quantitative western blotting
Brain samples from adult transgenic mice and wild-type
littermates were sent to Kinexus Bioinformatics (Vancouver,
Canada) in order to monitor the tau and protein kinase Cc
(PKC c) phosphorylation patterns. Tissue lysates were prepared,
and western blottings were performed according to standard
protocols (KinetworksTM Immunoblotting Service) [21]. Separat-
ed mouse cerebral proteins were probed with 14 and 3 different
primary antibodies specific for pTau (Ser199, Ser199/202, Ser396 and
Ser404) and PKC c (T514, T655 and T674) phosphosites, respec-
tively, followed by an overnight incubation with specific secondary
antibodies. Bands were visualized using enhanced chemilumines-
cense (ECL), and signals were collected using a highly sensitive 16-
bit camera, detected with a Bio-Rad FluorS Max Multi-imager,
normalized to time (60 seconds) and expressed as counts per
minute (cpm) [21]. Phosphorylation of tau and PKC c at specific
sites in wild-type brains was classified as 100% baseline.
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Golgi-Cox staining
Aging wild-type (n = 4) and transgenic animals (n = 4) were
sacrified by cervical dislocation, and the brains were removed.
Golgi staining was performed using FD Rapid GolgiStain Kit (FD
NeuroTechnologies) according to the manufacturer instructions.
Briefly, brains were sliced into 10 mm blocks and were immersed
into Golgi-Cox impregnation solution in the dark at room
temperature for 3 weeks. Then 100 mm coronal sections were
cut using a Microm HM 650 vibratome. Sections were collected in
PBS and were mounted on gelatin-coated microscope slides..
Finally, sections were allowed to dry for 24 hours, then rinsed in
distilled water for 4 minutes, After washing sections were
dehydrated in 50%, 75% and 95% ethanol, for 4 minutes each,
finally in absolute ethanol for 16 minutes. Dehydration was
followed by clearing slides in xylene for 12 minutes, and sections
were coverslipped with DPX mountant medium.
Dendritic spines were counted on neurons of stratum radiatum
in the hippocampal CA1 region. Proximal apical dendritic areas
were analysed at least 100 mm from the soma using a Zeiss light
microscope. Digital photos were taken about second-oredered
dendrites in 100 um length. Serial images were taken from each
dendrites which were then stacked into one file. For counting
dendritic spines we used the ImageJ 1,45 software. Dendritic
spines were counted separately by 3 experimenters blind to the
genotype.
Neuronal apoptosis
Neuronal apoptosis was monitored in the hippocampal region
of adult transgenic (n = 6) and wild-type mice (n = 6) using Fluoro-
Jade C (Millipore) staining [22]. Staining was performed on 8–
10 mm acetone fixed cryosections according to the manufacturer’s
protocol. Briefly, sections were dehydrated in descending alcohol
series and dipped into KMNO4 solution for 30 min, then stained
in 0.0004% Fluoro-Jade C (Millipore)-acetic acid solution for
30 min at room temperature protected from light. Stained sections
were visualized using a fluorescent microscope (Nikon Eclipse
E600) equipped with a 525-nm filter.
Electrophysiological recordings
Hippocampal slices 350 mm in thickness were prepared from
the brains of young and adult mice using a McIlwain tissue
chopper (Campden Instruments, Loughborough, UK). Slices were
incubated in standard artificial cerebrospinal fluid (ACSF) at room
temperature for 60 min while constantly gassed with 95% O2, 5%
CO2. ACSF was composed of 130 mM NaCl; 3.5 mM KCl;
2 mM CaCl2; 2 mM MgCl2; 0.96 mM NaH2PO4; 24 mM
NaHCO3; 10 mM D-glucose, pH 7.4. Individual slices were
transferred to a 3D-MEA chip with 60 tip-shaped and 60 mm high
electrodes spaced by 200 mm (Ayanda Biosystems, S.A., Lausanne,
Switzerland). The surrounding solution was quickly removed, and
the slice was immobilized using a grid. The slice was continuously
perfused with oxygenated ACSF (1.5 ml/min at 34uC) throughout
the entire recording session. Data were recorded using a standard,
commercially available MEA setup (Multi Channel Systems MCS
GmbH, Reutlingen, Germany).
Stimulation protocol
The Schaffer-collateral was stimulated by injecting a biphasic
current waveform (2100/+100 ms) through one selected electrode
at 0.033 Hz. Care was taken to place the stimulating electrode in
the same region from one slice to the next. The peak-to-peak
amplitudes of fEPSPs at the stratum pyramidale and stratum
radiatum of CA1 were analyzed. After a 30-min incubation
period, the threshold and maximum stimulation intensities for
evoked responses were determined. To evoke responses, 30% of
the maximal stimulation intensity was used. Following a stable 10-
min control sequence, a paired-pulse protocol was applied. Briefly,
two stimulation pulses were injected with interstimulus intervals of
50, 100 and 200 ms over 0.033 Hz. Three data points were
obtained at every interstimulus interval.
LTP and depotentiation protocol
Following a 10-min stable control sequence, LTP was induced
using a theta-burst stimulation (TBS) protocol applied at the
maximum stimulation intensity. TBS included four trains admin-
istered at 20 s intervals with 10 bursts at 5 Hz per train and 4
pulses given at 100 Hz per burst. LTP followed for 60 min, and
depotentiation was the induced using low-frequency stimulation of
3 Hz for 5 min at maximum intensity. Depotentiated responses
were followed for 30 min.
Statistical analyses
Transgenic and wild-type groups were compared by one-way
analysis of variance (ANOVA) followed by Bonferroni’s post-hoc
comparison and Student t-tests. Results were considered to be
significantly different at a probability level of p,0.05. Data are
presented as means 6 SEM.
Results
Measurement of serum triglyceride levels
ApoB-100 transgenic mice were generated in our laboratory as
described previously [16]. We have previously demonstrated that
human ApoB-100 protein is expressed at high levels in the liver
and serum of transgenic mice [17,23]. This time serum triglyceride
levels in young and aging transgenic mice (n = 6) and their wild-
type littermates (n = 6) were measured. ApoB-100 transgenic mice
presented higher serum triglyceride levels (2.40 mmol/l60.10) at
the age of 3 months compared to their wild-type littermates
(1.42 mmol/l60.11), with a statistically significant difference of
p,0.01. The difference in serum triglyceride levels persisted in
aging transgenic mice as well, presenting a serum triglyceride level
of 2.06 mmol/l60.08 versus 1.40 mmol/l60.05 in wild-type
littermates, (p,0.01) (Figure 1A).
Cerebral lipid metabolism
Next, we were interested in understanding whether chronically
elevated serum triglyceride and ApoB-100 levels would affect
cerebral lipid metabolism in transgenic mice. Consistent with the
increased serum triglyceride level, cerebral triglycerides were
markedly increased in cortical and hippocampal regions of aging
transgenic mice revealed by Nile-red staining (Figure 1B).
Moreover, in some cases triglyceride accumulation led to the
Figure 1. Detection of increased triglyceride levels in the serum and cerebral tissues of ApoB-100 transgenic mice. A) Serum
triglyceride levels of 3- and 9-month-old wild-type (WT, n = 6) and ApoB-100 transgenic (TG) mice (n = 6). Values represent the mean triglyceride level
(mmol/l) 6 SEM, ** denotes statistical significant difference of p,0.01. B) Detection of triglycerides in the brain of 10-month-old wild-type (WT) and
ApoB-100 transgenic mice (TG) using Nile-red staining (n = 3). Scale bars denotes 100 mm. White arrow indicates accumulation of triglycerides as lipid
droplet in the cortex of aging transgenic mice.
doi:10.1371/journal.pone.0046007.g001
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formation of large cortical lipid droplets in aging transgenic mice
(Figure 1B). However, no substantial changes were detected in the
cerebral cholesterol level of aging ApoB-100 transgenics compared
to wild-type littermates using filipin staining (Figure S1).
Next, we analyzed the expression of major apolipoproteins in
the cortical region of adult ApoB-100 transgenics using western
blotting. Suprisingly high level of ApoB-100 protein was detected
in the cortex of adult transgenics while, the protein was not
detectable in wild-type mice (Figure 2A). Cortical ApoE and LDL
Figure 2. Cortical lipoprotein profile of hyperlipidemic transgenic mice. A) Detection of major apolipoprotein and LDLr levels in the cortex
of adult (6 month old) wild-type (WT) (n = 3) and ApoB-100 transgenic (TG) mice (n = 3) using western blotting. B) Quantification of western blot
experiments. Relative OD values were expressed as % of wild-type mice (100%), 6 SEM, * denotes a statistical difference of p,0.05.
doi:10.1371/journal.pone.0046007.g002
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Figure 3. Increased expression of ApoB-100 and ApoE proteins in the cortical and hippocampal tissues of ApoB-100 transgenic (TG)
mice. Immunohistochemical detection of ApoB-100 in the cortex (upper row) and ApoE in the hippocampal region (lower row) of adult wild-type
(WT) and ApoB-100 transgenic (TG) animals. Magnification 2006. Scale bars represent 100 mm.
doi:10.1371/journal.pone.0046007.g003
Figure 4. Increased expression of pTau Ser404 in transgenic animals. A) Representative picture of pTau Ser404 and amyloid precursor protein
(APP) detection in young (3 month old) and adult (6-month-old) wild-type (WT) and ApoB-100 transgenic (TG) brain samples using western analysis B)
Quantitative evaluation of western blots, (n = 3), 6 SEM, * denotes statistically significant difference of p,0.05. C) Immunostaining of cortical and
hippocampal regions from wild-type (WT) and ApoB-100 transgenic (TG) mice (n = 3) using anti-pTauSer404. Arrows indicate somatodendritic
localization of hyperphosphorylated tau. HiF: hippocampal fissure; Mol: molecular layer of dentate gyrus. Scale bars represent 200 mm and 100 mm for
the cortex and hippocampus, respectively.
doi:10.1371/journal.pone.0046007.g004
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receptor levels were also significantly increased in transgenics
compared to wild-type mice (p,0.01 and p,0.05, respectively).
However, there was an apparent decrease in ApoA-I expression in
the cortex of transgenic versus wild-type mice (p,0.05) (Figure 2A).
Immunostainings confirmed increased level of ApoB-100 and
ApoE proteins in the cortical and hippocampal regions of adult
transgenic mice, respectively (Figure 3).
Phosphorylation pattern of tau and PKCc proteins
Our next goal was to reveal the possible impact of chronic
hypertriglyceridemia and elevated ApoB-100 level on tau phos-
phorylation. Hyperphosphorylation of tau protein is one of the key
factors in the development of neurodegenerative diseases. Phos-
phorylation intensity of pTau at sites Ser199, Ser199/202, Ser262,
Ser396 and Ser404 was investigated in young (3 month old) and
adult (6 month old) transgenic mouse brains using semiquantita-
tive- and quantitative-western blottings. Significantly increased
phosphorylation of pTau Ser404 was detected in brain lysates of
transgenic animals as young as 3 months old (p,0.05), and this
phosphorylation was further increased in the adult animals
(p,0.05) (Figure 4A and 4B). Hyperphosphorylated pTau Ser404
was localized to somatodendritic areas of the cortex and
demonstrated enhanced staining in the hippocampus, specifically
in the hippocampal fissure and molecular layer of the dentate
gyrus (Figure 4C). Tau phosphorylation at Ser199/Ser202, Ser262
and Ser396 sites showed no substantial alterations in young
transgenic animals versus wild-type mice (Figure 5A). Tau
phosphorylation was further investigated by quantitative western
analyses using 14 different commercially available antibodies
specific for 4 different phosphosites of tau protein. Tau phosphor-
ylation was considerably increased in transgenic mice, specifically
at site Ser199 (with an average of 101.75%), Ser396 (with an average
of 81.33%), Ser404 (with an average of 71.33%) and Ser199/202
(with an average of 53.25%) (Figure 5B).
Figure 5. Increased tau phosphorylation in the brain of adult (6 month old) ApoB-100 transgenic mice. A) Tau phosphorylation
intensities were compared in the cortex of young (3 month-old) wild-type (WT, n = 3) and ApoB-100 transgenic (TG) mice (n = 3), using conventional,
semi-quantitative western blottings. B) Quantification of western blots. First, Tau V-20 was normalized to the endogeneous b-actin, then different
phosphosites to Tau V-20. C) Quantitative western analysis of adult (6 month old) wild-type (WT) and transgenic (TG) brain lysates. Phosphorylation
level at different tau sites in wild-type mice represents 100%.
doi:10.1371/journal.pone.0046007.g005
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Amyloid plaque formation
In addition to tau hyperphosphorylation, another pathological
characteristic of Alzheimer’s disease is the deposition of toxic Ab
peptides, aberrant cleavage products of amyloid precursor protein
(APP), and formation of amyloid plaques in the brain. First, the
expression level of APP in transgenic and wild-type brains was
compared. APP level was increasing as the mice were getting
older, with no difference between transgenic and wild type animals
both at young or adult ages (Figure 4A). Amyloid plaque formation
was further studied on brain slices of adult and aging animals by
immunostaining using anti-Abeta (1–42) polyclonal antibody and
Congo-Red staining. Brain sections from a widely used Alzhei-
mer’s disease mouse model (APPswe6PSEN1dE9) were used as
positive control [24]. Although numerous amyloid plaques were
detected on the cortical and hippocampal sections of AD mouse
model, no plaque formation was observed on the corresponding
brain sections of aging wild-type and transgenic mice (Figure 6A
and 6B).
Neuronal degeneration
Abnormal tau hyperphosphorylation results in disruption of
axonal tubular network, which, in turn, leads to neuronal
degeneration [11]. Neuronal degeneration was investigated by
comparing dendritic spine densities in aging wild-type (n = 4) and
transgenic mice (n = 4). Dendritic spines were counted on neurons
of stratum radiatum in the hippocampal CA1 region after Golgi-
Cox staining. Transgenic mice had shorter and fewer dendritic
spines than wild-type controls (an average of 47.7863.79 and
63.68610.7, respectively) (Figure 7A). Although the difference
between wild-type and transgenic groups was not statistically
significant, however it showed a strong trend (p,0.053)
(Figure 7A).
Neuronal apoptosis was studied using Fluoro-Jade C staining.
This dye specifically stains degenerated neurons, independetly the
mechanism of degeneration. Moreover, it not merely stains
degenerated somas, but it is able to stain distal dendrites, axons
and nerve terminals [22]. Degenerated neurons were counted in 5
microscopic fields (600 mm6600 mm) on hippocampal sections of
transgenic (n = 6) and wild-type animals (n = 6). Significantly
increased degenerated neurons were counted in the hippocampal
region of adult transgenics versus wild-type mice (an average of
56.3661.58 and 39.8960.96, respectively) p,0.001 (Figure 7B).
Electrophysiological recordings
To determine whether biochemical and molecular biological
changes in the brain of ApoB-100 transgenic animals influence
presynaptic function, we performed. electrophysiological record-
ings on hippocampal slices of young and adult transgenic and wild-
type mice. A total of 6 animals per group were tested, with an
average of 5 electrodes recorded per slice. No significant
differences were detected in the overall excitability of the slices
(Figure 8A). A paired pulse protocol was applied with different
interstimulus intervals (50, 100 and 200 ms). The amplitude of the
2nd fEPSP is expected to be greater than that of the 1st fEPSP in
Figure 6. No amyloid plaques were detected in transgenic mice using immunohistochemistry. Immunohistochemical staining of b-
amyloid plaques using A) anti-Ab (1–42) polyclonal antibody B) congo-red staining on cerebral sections of aging (10 month old) wild-type (WT, n = 3),
ApoB-100 transgenic (TG, n = 3), and AD model (APPSwe6PSEN1dE9) mice (n = 3). Nuclei were stained using hematoxylin stain. Arrows indicate
stained amyloid plaques. Scale bars represent 100 mm (A) and 200 mm (B).
doi:10.1371/journal.pone.0046007.g006
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the CA1 region. This paired pulse facilitation (PPF) is used to
assess presynaptic function. There were significant differences in
the PPF ratio in apoB-100 transgenic mice compared to their wild-
type littermates (Figure 8A). ApoB-100-overexpressing mice
exhibited smaller PPF ratios at each interstimulus interval
(1.3560.01 at 50 ms, 1.3460.01 at 100 ms and 1.2160.01 at
200 ms at the age of 3 months, and 1.2760.01 at 50 ms,
1.2960.01 at 100 ms and 1.1760.01 at 200 ms at 6 months)
compared to wild-type littermates (1.6860.062 at 50 ms,
1.6360.01 at 100 ms and 1.3560.02 at 200 ms at the age of 3
months, and 1.5360.01 at 50 ms, 1.4960.01 at 100 ms and
1.3260.01 at 200 ms at 6 months; p,0.05 ANOVA, posthoc
Bonferroni) (Figure 8A). In addition, aging itself affected presyn-
aptic function, with adult mice exhibiting decreased PPF ratios
compared to young mice, regardless of genotype (Figure 8A).
Long-term synaptic plasticity was measured by applying theta-
burst stimulation to induce LTP. After 60 min, evoked responses
were depotentiated using low-frequency stimulation (LFS). Slices
from young ApoB-100 transgenic mice showed reduced LTP
compared to wild-type slices [176613% in transgenic mice and
343646% in wild-type mice 60 min after theta-burst stimulation
(TBS)] (Figure 8B). However, adult mice displayed the same level
of potentiation regardless of genotype (168610% in transgenic
mice and 173611% in wild-type mice 60 min after TBS)
(Figure 8B). The rate of low frequency stimulation-induced
depotentiation did not differ between the groups. When establish-
ing the 15 min pre-LFS sequence as 100%, the amplitude of
fEPSPs was 79610% in young wild-type mice versus 75612% in
transgenic mice (Figure 8B). Thirty minutes after LFS, the
amplitude of fEPSPs was 83612% in adult wild-type mice versus
8068% in transgenic mice (Figure 8B).
Next, expression of PKCc protein and its phosphorylation
intensity at T514, T655 and T674 phosphosites were investigated
using quantitative western analyses. The expression of the protein
was reduced by half and this change was reflected at every
phosphosites (T514, T655 and T674) involved in the investigation
(Figure 8C).
Discussion
Previously, in our and other laboratories were also shown that
overexpression of ApoB-100 in transgenic animals is accompanied
by increased serum triglyceride levels [17,25]. Under normal
physiological conditions neither large serum lipoproteins (i.e
ApoB-100) nor free cholesterol, triglycerides or other serum lipids
are able to cross the blood-brain barrier (BBB). Nevertheless, we
have detected high levels of plasma-derived ApoB-100 protein in
brain tissues, indicating the dysfunction of the BBB, possibly due to
chronic hyperlipidemia. Earlier findings are in agreement with our
results and suggest that hypertriglyceridemia may contribute to
endothelial dysfunction [26] likely through the generation of
oxidative stress.
Here, we demonstrate that in hypertriglyceridemic transgenic
mice tau is hyperphosphorylated at several sites and neurodegen-
Figure 7. Increased neurodegeneration in ApoB-100 transgenic mice. A) Dendritic spine density in the hippocampus of aging wild-type (WT,
n = 4) and transgenic (TG, n = 4) mice. Statistical analysis revealed a strong trend between genotypes (p,0.053). B) Detection of degenerated neurons
in the hippocampal region of wild-type (WT) and ApoB-100 transgenic (TG) mice using Fluoro-Jade C staining (n = 6). Arrows indicate fluorescent
degenerated neurons. Scale bars denote 200 mm. Quantification of degenerated neurons in the hippocampal region of wild-type (WT, n = 6) and
ApoB-100 transgenic (TG) brains (n = 6), 6 SEM, *** indicates a statistical difference of p,0.001.
doi:10.1371/journal.pone.0046007.g007
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eration develops in adult animals without notable b-amyloid
deposition. Under normal circumstancies amyloid production and
degradation/clearance is balanced. Alzheimer’s disease is associ-
ated with impaired clearance of b-amyloid from the brain, a
process normally facilitated by ApoE [27]. After acute treatment of
APP/PSE1 mice with bexarotene, an RXR agonist and inducer of
ApoE expression, rapid removal of both diffuse and compact
Abeta plaques was observed [27]. In ApoB-100 transgenic mice
we found that the production of b-amyloid – at least via APP- was
not enhanced. On the other hand a substantial increase of ApoE
expression in the cortex of ApoB transgenics was detected
indicating an enhanced b-amyloid clearance. This result is in
accordance with earlier report of Sparks et al. who demonstrated
an increased density of cortical and hippocampal ApoE-immuno-
reactive neurons in rabbits fed a 2% cholesterol diet [28]. Other in
vitro and in vivo studies also confirm that ApoE enhances cellular
Abeta uptake and degradation [15,29].
The binding of tau protein to microtubules is a phosphorylation
dependent event, that is a result of equilibrium between tau kinases
and phosphatases [30]. Hyperphosphorylation of tau has been
demonstrated to increase dynamic instability, leading to disinte-
gration of microtubular networks and eventually to formation of
neurofibrillary tangles (NFT) [30,31]. Antibodies recognizing
pTau Ser199, Ser202, Se262, Ser396 and Ser404 are frequently used
as AD diagnostic antibodies [32] indicating their important role in
NTF formation in AD. A notable increase in tau phosphorylation
was detected in adult ApoB-100 transgenic mice using these
antibodies from different sources. Moreover, we observed an
apparent increase in tau phosphorylation at phosphosite Ser404 in
young (3 month old) transgenic mice.
In AD b-amyloid binds to and activates b2 adrenergic receptor
signaling leading to subsequent activation of different serine and
threonine protein kinases, which eventually result in enhanced tau
phosphorylation [33]. In our transgenic strain tau hyperpho-
sphorylation and neurodegeneration develop in the absence of
amyloid plaques. Previous findings in transgenic mice overex-
pressing the familial AD mutant form of presenilin-1 (PS1) [34] or
in conditional knockout PS1 mice generated on a PS2 null mutant
background, show abnormal tau hyperphosphorylation, robust
brain atrophy, impaired learning and memory and AD-like
neurodegeneration in the absence of b-amyloid deposition [35].
However, the mechanism through ApoB-100 excess and hyper-
triglyceridemia can cause tau hyperphosphorylation remains to be
elucidated. It has been previously shown that dietary and
genetically-induced oxidative stress,- known to be present in our
transgenic animals due to the impaired cortical microvascular
density [4]-, may trigger tau hyperphosphorylation [36]. Another
plausible explanation derives from the decreased arterial flow
through the atherosclerotic vessels which in turn contributes to
decreased glucose availability in the brain, a well known cause of
tau hyperphosphorylation in the hippocampal and cortical tissues
of mice [18].
It has been previously demonstrated that elevated serum
triglyceride impairs NMDA-dependent hippocampal long-term
synaptic potentiation, which may result in reduced hippocampal-
dependent learning and memory [37]. Obesity and hypertriglyc-
eridemia have also been shown to result in cognitive impairment
that may be improved by a selective reduction in serum
triglycerides [37]. In agreement with these findings we also
recorded impaired presynaptic function and reduced long-term
potentiation in hypertriglyceridemic transgenic mice very early, at
3 months of age. Pharmacological and electrophysiological studies
have shown that several neuronal functions, including long term
potentiation (LTP) and long term depression (LTD), specifically
require PKC c [38]. PKC c deficient mice have modified long
term potentiation (LTP) in the hippocampus, and exhibit mild
deficits in spatial and contextual learning [39,40]. In agreement
with these previous results we have also found that PKC c
expression was decreased by half in the brain of adult ApoB-100
transgenic mice.
The interrelationship between hyperlipidemia/hypertryglicer-
idemia, cerebral vascular disorders and age related neurodegen-
erative disorders is a very plausible and discussed hypothesis. This
study provides evidence that elevated ApoB-100 level accompa-
nied by chronic hypertriglyceridemia can effect early on tau
phosphorylation, and is linked to impaired neuronal function and
widespread neuronal death in ApoB-100 transgenic mice. Based
on the phenotype described above, our ApoB-100 transgenic
model contributes to the understanding of hyperlipidemia-induced
age-related neurodegeneration.
Supporting Information
Figure S1 Cerebral cholesterol level in wild-type and
ApoB-100 transgenic mice. Cholesterol was stained in the
cerebral tissues of 10 month old wild-type (WT, n = 3) and
transgenic (TG) mice (n = 3) using filipin dye. Nuclei were
counterstained with propidium iodide (PI) stain. Magnification
2006. Scale bars indicate 100 mm.
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